Ampliphi Biosciences Corp (NYSE:APHB) was the recipient of a significant growth in short interest in October. As of October 13th, there was short interest totalling 836,702 shares, a growth of 1.4% from the September 29th total of 825,381 shares. Approximately 9.8% of the shares of the stock are sold short. Based on an average daily volume of 860,292 shares, the days-to-cover ratio is currently 1.0 days.

Shares of Ampliphi Biosciences Corp (APHB) opened at 1.20 on Wednesday. The company’s 50 day moving average price is $0.85 and its 200 day moving average price is $1.08. The stock’s market cap is $10.50 million. Ampliphi Biosciences Corp has a 52-week low of $0.67 and a 52-week high of $13.20.

COPYRIGHT VIOLATION WARNING: “Short Interest in Ampliphi Biosciences Corp (APHB) Expands By 1.4%” was posted by American Banking News and is owned by of American Banking News. If you are accessing this piece of content on another publication, it was copied illegally and republished in violation of US and international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/10/25/short-interest-in-ampliphi-biosciences-corp-aphb-expands-by-1-4.html.

Ampliphi Biosciences Corp Company Profile

AmpliPhi Biosciences Corporation is a biotechnology company. The Company is focused on the discovery, development and commercialization of phage therapeutics. The Company is engaged in identifying, characterizing and developing naturally occurring bacteriophages with its collaboration partners in bacteriophage biology, synthetic biology and manufacturing, to develop second-generation bacteriophage products.

Receive News & Ratings for Ampliphi Biosciences Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences Corp and related companies with MarketBeat.com's FREE daily email newsletter.